Fig. 2

Discussed topics during pre-test counseling. The figure shows the percentage of patients who reported whether the following topics were discussed: (1) women with ovarian cancer and a pathogenic variant in an ovarian cancer gene can sometimes receive additional treatment if the ovarian cancer comes back later, (2) for family members it may be important to know if a woman with ovarian cancer has a pathogenic variant in an ovarian cancer gene, and (3) when a woman with ovarian cancer has a pathogenic variant in a BRCA1 or BRCA2 gene, she also has a higher chance of developing breast cancer. *p ≤ 0.05